Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martin E. Andersson
Observed names:
Andersson, Martin,
M.E. Andersson,
Martin Andersson,
Martin E Andersson
Institution:
Sprint Bioscience (Sweden)
Observed institutions:
Stockholm University,
University of Oslo,
Peking University,
Sprint Bioscience (Sweden),
AlbaNova,
AstraZeneca (Sweden),
Technische Universität Berlin
show all 7
ORCID:
0009-0001-5999-5482
Observed ORCID:
0009-0001-5999-5482
OpenAlex ID:
A5009759742
Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy
2020
·
Muhammad Zaeem Noman
, Santiago Parpal
, et al.
·
Science Advances
·
262
PDF
New insight into the structure and function of the alternative oxidase
2000
·
Deborah A Berthold
, Martin E Andersson
, et al.
·
Biochimica et Biophysica Acta (BBA) - Bioenergetics
·
199
PDF
Displacement of the tyrosyl radical cofactor in ribonucleotide reductase obtained by single-crystal high-field EPR and 1.4-Å x-ray data
2003
·
Martin Högbom
, Marcus Galander
, et al.
·
Proceedings of the National Academy of Sciences
·
159
A revised model of the active site of alternative oxidase
1999
·
Martin E Andersson
, Pär Nordlund
·
FEBS Letters
·
155
Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
2018
·
Nina M. S. Gustafsson
, Katarina Färnegårdh
, et al.
·
Nature Communications
·
128
PDF
The Crystal Structure of an Azide Complex of the Diferrous R2 Subunit of Ribonucleotide Reductase Displays a Novel Carboxylate Shift with Important Mechanistic Implications for Diiron-Catalyzed Oxygen Activation
1999
·
Martin E. Andersson
, Martin Högbom
, et al.
·
Journal of the American Chemical Society
·
108
Current methods for phosphoprotein isolation and enrichment
2006
·
Stefan R. Schmidt
, Fritz Schweikart
, et al.
·
Journal of Chromatography B
·
74
Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target
2017
·
Manuel Ellermann
, Ashley Eheim
, et al.
·
ACS Chemical Biology
·
56
Crystal structures of oxidized dinuclear manganese centres in Mn-substituted class I ribonucleotide reductase from Escherichia coli: carboxylate shifts with implications for O2 activation and radical generation
2001
·
Martin Högbom
, Martin E. Andersson
, et al.
·
JBIC Journal of Biological Inorganic Chemistry
·
47
Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design
2018
·
Fredrik Rahm
, Jenny Viklund
, et al.
·
Journal of Medicinal Chemistry
·
32
PDF
Restoring Proper Radical Generation by Azide Binding to the Iron Site of the E238A Mutant R2 Protein of Ribonucleotide Reductase fromEscherichia coli
2001
·
Maria Assarsson
, Martin E. Andersson
, et al.
·
Journal of Biological Chemistry
·
23
Structural and Mutational Studies of the Carboxylate Cluster in Iron-Free Ribonucleotide Reductase R2
2004
·
Martin E. Andersson
, Martin Högbom
, et al.
·
Biochemistry
·
16
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti‐tumor efficacy
2024
·
Yasmin Yu
, Madhumita Bogdan
, et al.
·
Molecular Oncology
·
14
Expression, purification, crystallization and preliminary diffraction studies of the tRNA pseudouridine synthase TruD fromEscherichia coli
2004
·
Ulrika B. Ericsson
, Martin E. Andersson
, et al.
·
Acta Crystallographica Section D Biological Crystallography
·
6
Abstract 2116: VPS34 inhibitor SB02024 activates cGAS-STING signaling and sensitizes tumors to STING agonist
2022
·
Yasmin Yu
, Muhammad Z. Noman
, et al.
·
Cancer Research
·
3
DCPS is a synthetic lethal therapeutic target in acute myeloid leukemia expressing low levels of FHIT
2025
·
Francesca Grassi
, Madhurendra Singh
, et al.
·
Leukemia
·
2
PDF
Development of Inhibitors of PIP4K2 As a Treatment for Patients with Hematologic Malignancies
2018
·
David L McElligott
, Edward Kesicki
, et al.
·
Blood
·
2
Abstract 7727: Integrated FHIT and IDH2 biomarkers predict synthetic lethal response to DCPS inhibition in acute myeloid leukemia
2026
·
Madhurendra Singh
, Francesca Grassi
, et al.
·
Cancer Research
Integrated FHIT and IDH2 biomarker profiling predicts lethal sensitivity to DCPS inhibition in Acute Myeloid Leukemia and Myelodysplastic syndrome
2026
·
Francesca Grassi
, Lisa Bast
, et al.
·
Discover Oncology
Abstract A063: Inhibition of TREX1 increases type I interferon signaling and reduces tumor growth in vivo
2025
·
Madhurendra Singh
, Camilla Silvander
, et al.
·
Cancer Immunology Research
Author response for "Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti‐tumor efficacy"
2024
·
Yasmin Yu
, Madhumita Bogdan
, et al.
·
Publons reviews and discussion
Abstract 689: Identification and optimization of novel chemical matter via a structure-based approach resulting in a probe for MTH1
2018
·
Marcus Bauser
, Anja Giese
, et al.
·
Cancer Research
The Advantages of Micro-Cal™ Auto-iTC200 for Secondary Screening in a Fragment-based Drug Discovery Campaign
2013
·
Markova, Natalia
, O'Brien, Ronan
, et al.
·
Europe PMC (PubMed Central)
azide complex of the diferrous F208A mutant R2 subunit of ribonucleotide reductase
2003
·
M.E. Andersson
, M. Hogbom
, et al.
·
Worldwide Protein Data Bank
Conformation of the tyrosyl radical in escherichia coli ribonucleotide reductase R2
2003
·
Martin Högborn
, Martin Andersson
, et al.
·
Journal of Inorganic Biochemistry
Show more works
View as search
Works count:
28
Citation count:
1,286
H-index:
13
I10-index:
13
Year
Topic
Type
